You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

RAEB-t

Showing 26 - 50 of 8,020
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    CX3CR1+T Cell Predict Immunotherapy Efficacy

    Recruiting
    • Non-small Cell Lung Cancer
    • PD-1 inhibitor based immunotherapy
    • Changsha, Hunan, China
    • +1 more
    Sep 19, 2023

    TINO: T Cells in the Nose of Older Adults

    Recruiting
    • Respiratory Tract Infections
    • Aging
      • Leiden, Zuid Holland, Netherlands
        Leiden University Medical Center
      Sep 8, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • Hangzhou, Zhejiang, China
        The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
      Aug 7, 2023

      Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

      Not yet recruiting
      • Prostate Carcinoma
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 17, 2023

      Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)

      Not yet recruiting
      • Head and Neck Cancer
      • +3 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Oct 18, 2023

      Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • BTK inhibitor
      • PD-1 inhibitor
      • Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      May 20, 2023

      CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

      Not yet recruiting
      • Lymphoma
      • Chimeric Antigen Receptor
      • (no location specified)
      Oct 24, 2023

      Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Aldesleukin
      • +12 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Aug 9, 2023

      Chronic Hepatitis B Trial in Beijing (TCR-T)

      Active, not recruiting
      • Chronic Hepatitis B
      • TCR-T
      • Beijing, China
        The Fifth Medical Center of PLA General Hospital
      Jun 13, 2023

      Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

      Not yet recruiting
      • Metastatic Solid Tumor
      • TAC01-CLDN18.2
      • (no location specified)
      May 8, 2023

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • La Jolla, California
      • +7 more
      Aug 25, 2023

      T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

      Not yet recruiting
      • T-Cell Non-Hodgkin Lymphoma
      • +14 more
      • WU-CART-007
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 17, 2023

      Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

      Not yet recruiting
      • Recurrent Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Biospecimen Collection
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Mar 24, 2023

      Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

      Not yet recruiting
      • Metastatic Colorectal Adenocarcinoma
      • +5 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 12, 2023

      Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • +2 more
      • Biopsy
      • +11 more
      • Duarte, California
        City of Hope Medical Center
      Aug 7, 2023

      Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

      Recruiting
      • Brain Cancer
      • +4 more
      • Trastuzumab deruxtecan
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Sep 22, 2023

      T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

      Withdrawn
      • T-cell Acute Lymphoblastic Leukemia
      • T-lymphoblastic Lymphoma
      • Target CD7 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force of People's Libe
      Nov 23, 2022

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

      Recruiting
      • Refractory Acute Myeloid Leukemia
      • +4 more
      • CD371-YSNVZ-IL18 CAR T cells
      • Basking Ridge, New Jersey
      • +6 more
      Aug 29, 2023

      B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • Autologous Anti-CD19 CAR-expressing T Lymphocytes
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Jan 30, 2023

      Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

      Recruiting
      • Gastric Cancer
      • +6 more
      • CEA CAR-T cells
      • Nanchang, Jiangxi, China
        The First Affiliated Hospital of Nanchang University
      Aug 23, 2023